Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-30

Clinical Trial Update: Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection [Phase 2]

View source ↗

Summary

Phase 2 trial comparing contezolid acefosamil to linezolid for acute bacterial skin and skin structure infections has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Contezolid Acefosamil (contezolid acefosamil)
  • Linezolid (Linezolid)

Snippet

Sponsor: MicuRx | Conditions: Skin Diseases, Bacterial, Gram-Positive Bacterial Infections | Phase 2 | Status: COMPLETED | Results posted: 2021-04-30